SEOUL, SK Biopharmaceuticals Co. on Monday reported its fourth-quarter net profit of 7.8 billion won (US$5.8 million), turning from a loss of 43.9 billion won a year earlier. Operating income for the October-December period was 15.2 billion, compared with a loss of 44.6 billion won a year ago, the company said in a regulatory filing. Revenue rose 101.9 percent to 126.8 billion won. Source: Yonhap News Agency
Myanmar Clears Path for Junta Leader to Become President
March 30, 2026